Bridgewater Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111M | Buy |
|
|||||
|
2025
Q1 | $22M | Sell |
|
|||||
|
2024
Q4 | $50.9M | Buy |
|
|||||
|
2024
Q3 | $40.4M | Sell |
|
|||||
|
2024
Q2 | $49.5M | Sell |
|
|||||
|
2024
Q1 | $81.9M | Sell |
|
|||||
|
2023
Q4 | $94.1M | Buy |
|
|||||
|
2023
Q3 | $85.9M | Sell |
|
|||||
|
2023
Q2 | $85.5M | Buy |
|
|||||
|
2023
Q1 | $65.6M | Buy |
|
|||||
|
2022
Q4 | $4.86M | Sell |
|
|||||
|
2022
Q3 | $28.6M | Buy |
|
|||||
|
2022
Q2 | $12.5M | Buy |
|
|||||
|
2022
Q1 | $12.2M | Buy |
|
|||||
|
2021
Q4 | $5.67M | Sell |
|
|||||
|
2021
Q3 | $8.1M | Buy |
|
|||||
|
2021
Q2 | $5.92M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $2.71M | Buy |
|